After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Diagnostics & Research industry segment, falling under the Healthcare sector. The current market capitalization of GeneDx Holdings Corp is $4.01B. A total of 0.68 million shares were traded on the day, compared to an average of 581.37K shares.
In the most recent transaction, Stueland Katherine sold 2,158 shares of WGS for 136.54 per share on Oct 29 ’25. After the transaction, the CHIEF EXECUTIVE OFFICER now owns 3,436 company shares. In a previous transaction on Oct 29 ’25, Feeley Kevin sold 388 shares at 136.54 per share. WGS shares that CHIEF FINANCIAL OFFICER owns now total 3,757.
Among the insiders who sold shares, Stueland Katherine disposed of 12,858 shares on Sep 30 ’25 at a per-share price of $108.17. This resulted in the CHIEF EXECUTIVE OFFICER holding 1,720 shares of WGS after the transaction. In another insider transaction, Feeley Kevin sold 6,609 shares at $108.38 per share on Sep 30 ’25. Company shares held by the CHIEF FINANCIAL OFFICER now total 3,392.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, WGS has a high of $146.00 and a low of $55.17.
As of this writing, WGS has an earnings estimate of $0.25 per share for the current quarter. EPS was calculated based on a consensus of 7.0 estimates, with a high estimate of $0.65 per share and a lower estimate of $0.01. The company reported an EPS of $0.64 in the last quarter
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. WGS’s latest balance sheet shows that the firm has $400.57M in Cash & Short Term Investments as of fiscal 2021. There were $11.00M in debt and $101.28M in liabilities at the time. Its Book Value Per Share was $10.12, while its Total Shareholder’s Equity was $388.10M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for WGS is Buy with a score of 4.56.
